{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:55:39Z","timestamp":1781484939582,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10067-025-07548-z","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:55:35Z","timestamp":1751554535000},"page":"3153-3166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-1941","authenticated-orcid":false,"given":"Nelson Luis","family":"Cahuapaza-Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5242-3141","authenticated-orcid":false,"given":"Cielo Cinthya","family":"Calderon-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0497-7042","authenticated-orcid":false,"given":"Tatiana Vanessa","family":"Villavicencio-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"7548_CR1","doi-asserted-by":"publisher","first-page":"112752","DOI":"10.1016\/j.bios.2020.112752","volume":"172","author":"M Y\u00fcce","year":"2021","unstructured":"Y\u00fcce M, Filiztekin E, \u00d6zkaya KG (2021) COVID-19 diagnosis - a review of current methods. Biosens Bioelectron 172:112752","journal-title":"Biosens Bioelectron"},{"issue":"2","key":"7548_CR2","doi-asserted-by":"publisher","first-page":"e00133","DOI":"10.1128\/CMR.00133-20","volume":"34","author":"A Synowiec","year":"2021","unstructured":"Synowiec A, Szczepa\u0144ski A, Barreto-Duran E, Lie LK, Pyrc K (2021) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection. Clin Microbiol Rev 34(2):e00133-e220","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"7548_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41440-020-0488-z","volume":"43","author":"MM Ciulla","year":"2020","unstructured":"Ciulla MM (2020) SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs\/ARBs. Hypertens Res 43(9):985\u2013986","journal-title":"Hypertens Res"},{"issue":"11","key":"7548_CR4","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/all.14429","volume":"75","author":"U Radzikowska","year":"2020","unstructured":"Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P et al (2020) Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 75(11):2829\u20132845","journal-title":"Allergy"},{"key":"7548_CR5","unstructured":"COVID-19 deaths | WHO COVID-19 dashboard. Available in: http:\/\/data.who.int\/dashboards\/covid19\/cases"},{"issue":"1","key":"7548_CR6","doi-asserted-by":"publisher","first-page":"2002083","DOI":"10.1080\/21645515.2021.2002083","volume":"18","author":"R Patel","year":"2022","unstructured":"Patel R, Kaki M, Potluri VS, Kahar P, Khanna D (2022) A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Hum Vaccin Immunother 18(1):2002083","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"7548_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/25785826.2022.2068331","volume":"45","author":"N Asghar","year":"2022","unstructured":"Asghar N, Mumtaz H, Syed AA, Eqbal F, Maharjan R, Bamboria A et al (2022) Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review. Immunological Medicine 45(4):225\u2013237","journal-title":"Immunological Medicine"},{"issue":"6","key":"7548_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa2116185","volume":"386","author":"LM Dunkle","year":"2022","unstructured":"Dunkle LM, Kotloff KL, Gay CL, \u00c1\u00f1ez G, Adelglass JM, Barrat Hern\u00e1ndez AQ et al (2022) Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico. N Engl J Med 386(6):531\u2013543","journal-title":"N Engl J Med"},{"issue":"1","key":"7548_CR9","doi-asserted-by":"publisher","first-page":"e2507","DOI":"10.1002\/rmv.2507","volume":"34","author":"J Beladiya","year":"2024","unstructured":"Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S et al (2024) Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials. Rev Med Virol 34(1):e2507","journal-title":"Rev Med Virol"},{"key":"7548_CR10","doi-asserted-by":"publisher","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","volume":"12","author":"N Sharif","year":"2021","unstructured":"Sharif N, Alzahrani KJ, Ahmed SN, Dey SK (2021) Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol 12:714170","journal-title":"Front Immunol"},{"issue":"1","key":"7548_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","volume":"29","author":"WY Chi","year":"2022","unstructured":"Chi WY, Li YD, Huang HC, Chan TEH, Chow SY, Su JH et al (2022) COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci 29(1):82","journal-title":"J Biomed Sci"},{"issue":"3","key":"7548_CR12","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1002\/iid3.807","volume":"11","author":"F Yasmin","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS et al (2023) Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis 11(3):e807","journal-title":"Immun Inflamm Dis"},{"issue":"1\u20132","key":"7548_CR13","first-page":"1","volume":"78","author":"F Allahyari","year":"2023","unstructured":"Allahyari F, Molaee H, Hosseini Nejad J (2023) Covid-19 vaccines and neurological complications: a systematic review. Z Naturforsch C J Biosci 78(1\u20132):1\u20138","journal-title":"Z Naturforsch C J Biosci"},{"issue":"13","key":"7548_CR14","doi-asserted-by":"publisher","first-page":"e37626","DOI":"10.1097\/MD.0000000000037626","volume":"103","author":"N Sandakly","year":"2024","unstructured":"Sandakly N, El Koubayati G, Sarkis J, Naderi S, Sebaaly D, Haddad F (2024) Kikuchi-Fujimoto disease associated with a flare-up of a leukocytoclastic vasculitis: a rare case report and review of literature. Medicine (Baltimore) 103(13):e37626","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"7548_CR15","first-page":"e17021","volume":"13","author":"Z Ahmed","year":"2021","unstructured":"Ahmed Z, Quadir H, Hakobyan K, Gaddam M, Kannan A, Ojinnaka U et al (2021) Kikuchi-Fujimoto disease: a rare cause of cervical lymphadenopathy. Cureus 13(8):e17021","journal-title":"Cureus"},{"issue":"2","key":"7548_CR16","first-page":"210","volume":"56","author":"C Cindy","year":"2024","unstructured":"Cindy C, Wibowo SAK, Ariane A, Hidayat R (2024) Kikuchi-Fujimoto disease preceding overlap syndrome of Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus: literature review based on a case report. Acta Med Indones 56(2):210\u2013217","journal-title":"Acta Med Indones"},{"issue":"16","key":"7548_CR17","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.12998\/wjcc.v11.i16.3664","volume":"11","author":"VK Mahajan","year":"2023","unstructured":"Mahajan VK, Sharma V, Sharma N, Rani R (2023) Kikuchi-Fujimoto disease: a comprehensive review. World J Clin Cases 11(16):3664\u20133679","journal-title":"World J Clin Cases"},{"issue":"2","key":"7548_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00296-021-05088-8","volume":"42","author":"A Masiak","year":"2022","unstructured":"Masiak A, Lass A, Kowalski J, Hajduk A, Zdrojewski Z (2022) Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review. Rheumatol Int 42(2):341\u2013348","journal-title":"Rheumatol Int"},{"issue":"1","key":"7548_CR19","first-page":"e21049","volume":"14","author":"HA Al Ghadeer","year":"2022","unstructured":"Al Ghadeer HA, AlKadhem SM, AlMajed MS, AlAmer HM, AlHabeeb JA, Alomran SH et al (2022) Kikuchi-Fujimoto disease following COVID-19. Cureus 14(1):e21049","journal-title":"Cureus"},{"issue":"1","key":"7548_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12308-021-00477-1","volume":"15","author":"Y Guan","year":"2022","unstructured":"Guan Y, Xia X (2022) Lu H (2022) Kikuchi-Fujimoto disease following vaccination against COVID-19. J Hematop 15(1):21\u201323","journal-title":"J Hematop"},{"issue":"1","key":"7548_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1","journal-title":"Syst Rev"},{"key":"7548_CR22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"7548_CR23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"issue":"11","key":"7548_CR24","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.ijporl.2014.08.019","volume":"78","author":"Y Chong","year":"2014","unstructured":"Chong Y, Kang CS (2014) Causative agents of Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): a meta-analysis. Int J Pediatr Otorhinolaryngol 78(11):1890\u20131897","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"7548_CR25","unstructured":"Hollingsworth HC, Peiper SC, Weiss LM, Raffeld M, Jaffe ES (1994) An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med 118(2):134\u201340."},{"issue":"12","key":"7548_CR26","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s00296-012-2562-6","volume":"33","author":"J Labrador","year":"2013","unstructured":"Labrador J, Aparicio MA, Santos-Briz A, Flores T, Garc\u00eda-Sanz R (2013) Kikuchi-Fujimoto disease: a case supporting a role for human herpesvirus 7 involvement in the pathogenesis. Rheumatol Int 33(12):3065\u20133068","journal-title":"Rheumatol Int"},{"issue":"1","key":"7548_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.semdp.2017.12.001","volume":"35","author":"C Barrionuevo-Cornejo","year":"2018","unstructured":"Barrionuevo-Cornejo C, Due\u00f1as-Hancco D (2018) Lymphadenopathies in human immunodeficiency virus infection. Semin Diagn Pathol 35(1):84\u201391","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"7548_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/vim.2006.0098","volume":"20","author":"WP Zhang","year":"2007","unstructured":"Zhang WP, Wang JH, Wang WQ, Chen XQ, Wang Z, Li YF et al (2007) An association between parvovirus B19 and Kikuchi-Fujimoto disease. Viral Immunol 20(3):421\u2013428","journal-title":"Viral Immunol"},{"issue":"2","key":"7548_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jmii.2019.08.016","volume":"54","author":"LC Chen","year":"2021","unstructured":"Chen LC, Wang CJ, Chang YC, Shie SS, Lin TY, Hsieh YC et al (2021) Distribution of lymphadenopathy in patients with Kikuchi disease. J Microbiol Immunol Infect 54(2):299\u2013304","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"7548_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10067-006-0230-5","volume":"26","author":"Y Kucukardali","year":"2007","unstructured":"Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M (2007) Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol 26(1):50\u201354","journal-title":"Clin Rheumatol"},{"issue":"4","key":"7548_CR31","doi-asserted-by":"publisher","first-page":"e2313","DOI":"10.1002\/rmv.2313","volume":"32","author":"I Hadj Hassine","year":"2022","unstructured":"Hadj Hassine I (2022) Covid-19 vaccines and variants of concern: a review. Rev Med Virol 32(4):e2313","journal-title":"Rev Med Virol"},{"key":"7548_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T et al (2022) COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther 7:146","journal-title":"Signal Transduct Target Ther"},{"key":"7548_CR33","doi-asserted-by":"crossref","unstructured":"Gra\u00f1a C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, et al (2022) Efficacy and safety of COVID-19 vaccines. Cochrane database Syst Rev 12(12):CD015477.","DOI":"10.1002\/14651858.CD015477"},{"issue":"1","key":"7548_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12902-023-01424-0","volume":"23","author":"AS Alsudais","year":"2023","unstructured":"Alsudais AS, Alkanani RS, Fathi AB, Almuntashiri SS, Jamjoom JN, Alzhrani MA et al (2023) Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports. BMC Endocr Disord 23(1):164","journal-title":"BMC Endocr Disord"},{"key":"7548_CR35","doi-asserted-by":"publisher","first-page":"108183","DOI":"10.1016\/j.clineuro.2024.108183","volume":"238","author":"MT Abuawwad","year":"2024","unstructured":"Abuawwad MT, Taha MJJ, Taha AJ, Kozaa YA, Falah O, Abuawwad IT et al (2024) Guillain-Barr\u00e9 syndrome after COVID-19 vaccination: a systematic review and analysis of case reports. Clin Neurol Neurosurg 238:108183","journal-title":"Clin Neurol Neurosurg"},{"key":"7548_CR36","doi-asserted-by":"crossref","unstructured":"Cahuapaza-Gutierrez NL (2024) Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series. Lupus 33(4):375\u201386.","DOI":"10.1177\/09612033241232054"},{"issue":"3","key":"7548_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/vaccines11030665","volume":"11","author":"J Liu","year":"2023","unstructured":"Liu J, Wu H, Xia SL (2023) New-onset arthritis following COVID-19 vaccination: a systematic review of case reports. Vaccines (Basel) 11(3):665","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"7548_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s15010-024-02217-w","volume":"52","author":"V Sanker","year":"2024","unstructured":"Sanker V, Mylavarapu M, Gupta P, Syed N, Shah M, Dondapati VVK (2024) Post COVID-19 vaccination medium vessel vasculitis: a systematic review of case reports. Infection 52(4):1207\u20131213","journal-title":"Infection"},{"issue":"1","key":"7548_CR39","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/rmv.70011","volume":"35","author":"O Al-Omoush","year":"2025","unstructured":"Al-Omoush O, Khalil L, Ramadan A, Tarakhan H, Alzoubi A, Nabil A et al (2025) Sarcoidosis and COVID-19 vaccines: a systematic review of case reports and case series. Rev Med Virol 35(1):e70011","journal-title":"Rev Med Virol"},{"issue":"9","key":"7548_CR40","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00431-012-1729-1","volume":"171","author":"T Watanabe","year":"2012","unstructured":"Watanabe T, Hashidate H, Hirayama Y, Iinuma Y (2012) Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis. Eur J Pediatr 171(9):1409\u20131411","journal-title":"Eur J Pediatr"},{"key":"7548_CR41","doi-asserted-by":"publisher","first-page":"1279592","DOI":"10.3389\/fimmu.2023.1279592","volume":"14","author":"JL Yu","year":"2023","unstructured":"Yu JL, Li Z, Zhang B, Huang YN, Zhao TY (2023) Case report: Kikuchi-Fujimoto disease: unveiling a case of recurrent fever and enlarged cervical lymph nodes in a young female patient with a literature review of the immune mechanism. Front Immunol 14:1279592","journal-title":"Front Immunol"},{"issue":"12","key":"7548_CR42","doi-asserted-by":"publisher","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","volume":"194","author":"L R\u00f6nnblom","year":"2001","unstructured":"R\u00f6nnblom L, Alm GV (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 194(12):F59-63","journal-title":"J Exp Med"},{"key":"7548_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-1-18","volume":"1","author":"X Bosch","year":"2006","unstructured":"Bosch X, Guilabert A (2006) Kikuchi-Fujimoto disease. Orphanet J Rare Dis 1:18","journal-title":"Orphanet J Rare Dis"},{"key":"7548_CR44","doi-asserted-by":"crossref","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19(3):155\u201370.","DOI":"10.1038\/s41579-020-00468-6"},{"key":"7548_CR45","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203(2):631\u20137.","DOI":"10.1002\/path.1570"},{"key":"7548_CR46","doi-asserted-by":"crossref","unstructured":"Wong DWL, Klinkhammer BM, Djudjaj S, Villwock S, Timm MC, Buhl EM, et al (2021) multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells 10(8):1900.","DOI":"10.3390\/cells10081900"},{"issue":"4","key":"7548_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41379-021-00992-7","volume":"35","author":"EY Li","year":"2022","unstructured":"Li EY, Xu J, Nelson ND, Teachey DT, Tan K, Romberg N et al (2022) Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response. Mod Pathol 35(4):462\u2013469","journal-title":"Mod Pathol"},{"issue":"3","key":"7548_CR48","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0002-9440(10)61767-1","volume":"159","author":"SA Pileri","year":"2001","unstructured":"Pileri SA, Facchetti F, Ascani S, Sabattini E, Poggi S, Piccioli M et al (2001) Myeloperoxidase expression by histiocytes in Kikuchi\u2019s and Kikuchi-like lymphadenopathy. Am J Pathol 159(3):915\u2013924","journal-title":"Am J Pathol"},{"issue":"2","key":"7548_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1309\/AJCP7V1QHJLOTKKJ","volume":"131","author":"ME Pilichowska","year":"2009","unstructured":"Pilichowska ME, Pinkus JL, Pinkus GS (2009) Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype. Am J Clin Pathol 131(2):174\u2013182","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"7548_CR50","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12967-022-03767-z","volume":"20","author":"R Karki","year":"2022","unstructured":"Karki R, Kanneganti TD (2022) Innate immunity, cytokine storm, and inflammatory cell death in COVID-19. J Transl Med 20(1):542","journal-title":"J Transl Med"},{"issue":"2","key":"7548_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/medicina58020144","volume":"58","author":"C Zanza","year":"2022","unstructured":"Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G et al (2022) Cytokine Storm in COVID-19: immunopathogenesis and therapy. Medicina (Kaunas) 58(2):144","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"7548_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1309\/YF081L4TKYWVYVPQ","volume":"122","author":"X Bosch","year":"2004","unstructured":"Bosch X, Guilabert A, Miquel R, Campo E (2004) Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol 122(1):141\u2013152","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"7548_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","volume":"21","author":"AJ Pollard","year":"2021","unstructured":"Pollard AJ, Bijker EM (2021) A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 21(2):83\u2013100","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"7548_CR54","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ (2017) Lipid nanoparticle systems for enabling gene therapies. Mol Ther 25(7):1467\u20131475","journal-title":"Mol Ther"},{"issue":"11","key":"7548_CR55","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lor\u00e9 K, Pardi N (2022) Innate immune mechanisms of mRNA vaccines. Immunity 55(11):1993\u20132005","journal-title":"Immunity"},{"issue":"5","key":"7548_CR56","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3324\/haematol.2021.280239","volume":"107","author":"G Caocci","year":"2022","unstructured":"Caocci G, Fanni D, Porru M, Greco M, Nemolato S, Firinu D et al (2022) Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination. Haematologica 107(5):1222\u20131225","journal-title":"Haematologica"},{"issue":"6","key":"7548_CR57","doi-asserted-by":"publisher","first-page":"e01414","DOI":"10.1002\/rcr2.1414","volume":"12","author":"CCD Leung","year":"2024","unstructured":"Leung CCD, Chan HCC, Chan MC, Chan YH, Ho MY, Chen CH et al (2024) Kikuchi-Fujimoto disease following SARS-CoV-2 infection: a rare disease with increased incidence during the COVID-19 pandemic? Respirol Case Rep 12(6):e01414","journal-title":"Respirol Case Rep"},{"issue":"1","key":"7548_CR58","first-page":"42","volume":"57","author":"G Moreno de Juan","year":"2024","unstructured":"Moreno de Juan G, P\u00e9rez Del Barrio A, Herrera Romero EG, Gonz\u00e1lez Ruiz M, Montes Moreno S (2024) Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: report of a case and literature review. Rev Esp Patol 57(1):42\u201347","journal-title":"Rev Esp Patol"},{"issue":"6","key":"7548_CR59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.23822\/EurAnnACI.1764-1489.273","volume":"55","author":"A Rodr\u00edguez-Ferreras","year":"2023","unstructured":"Rodr\u00edguez-Ferreras A, Maray I, Coya-Fern\u00e1ndez C, Octavio-Bocigas MM, Fern\u00e1ndez-Del R\u00edo MF, Casares-L\u00f3pez S et al (2023) Kikuchi-Fujimoto disease and COVID-19 vaccination: pharmacovigilance approach. Eur Ann Allergy Clin Immunol 55(6):278\u2013282","journal-title":"Eur Ann Allergy Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07548-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07548-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07548-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:07:50Z","timestamp":1757218070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07548-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7548"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07548-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The present review study does not require ethical approval because it is a study of synthesis and analysis of data from primary articles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}